Interpretation and Conclusions:
In summary, the care of patients with infected CIEDs is treacherous
territory that is associated with significant morbidity and mortality.
The use of leadless pacemakers, either as a permanent solution or
possibly as a prolonged temporary solution, may be another small step
forward in the improvement of outcomes in this difficult population of
patients.
While caution and clinical judgement are required to evaluate the unique
clinical scenario of each infected patient, the use of the Medtronic
leadless pacemaker in this setting shows promise.